SBIR Series 3/4
Research strategies, budgeting, preliminary data, and commercialization.
In this part, we will review the Research Strategy sections: Significance, Innovation and Approach. Budgeting will be discussed in detail. We will also review the importance of advisory committees, academic collaborators and the value of Preliminary Data. We will wrap up with the structure and requirements for the Commercialization section.
Event Speaker: Dr. Jim O’Halloran, ScienceDocs Consultant
Dr. O’Halloran has more than 17 years of experience with the SBIR program and has received funding from the National Institute on Aging (NIA), National Institute of Mental Health (NIMH) and the National Institute on Neurological Diseases and Stroke (NINDS). He has served as principal investigator on more than 20 grants, totaling more than $10M. He has also served as a selected reviewer for these same agencies for over a decade and is intimately familiar with the 5-axis proposal scoring processes and dynamics, upon which funding depends. As a deeply experienced reviewer, he is highly skilled on how best to emphasize a proposal’s strengths, avoid common pitfalls and tune proposals for review.